The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Open accessAbstract
To fulfill the bioenergetic and biosynthetic demand of proliferation, T cells reprogram their metabolic pathways from fatty acid β-oxidation and pyruvate oxidation via the TCA cycle to the glycolytic, pentose-phosphate, and glutaminolytic pathways. Two of the top-ranked candidate transcription factors potentially responsible for the activation-induced T cell metabolic transcriptome, HIF1α and Myc, were induced upon T cell activation, but only the acute deletion of Myc markedly inhibited activation-induced glycolysis and glutaminolysis in T cells. Glutamine deprivation compromised activation-induced T cell growth and proliferation, and this was partially replaced by nucleotides and polyamines, implicating glutamine as an important source for biosynthetic precursors in active T cells. Metabolic tracer analysis revealed a Myc-dependent metabolic pathway linking glutaminolysis to the biosynthesis of polyamines. Therefore, a Myc-dependent global metabolic transcriptome drives metabolic reprogramming in activated, primary T lymphocytes. This may represent a general mechanism for metabolic reprogramming under patho-physiological conditions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Transcription factor enrichment analysis revealed that formate-induced transcriptional changes were linked with enrichment in transcription factors regulating proliferation and metabolism, effector function, and differentiation and epigenetic control.
“Transcription factor enrichment analysis73 revealed that formate-induced transcriptional changes were linked with an enrichment in transcription factors regulating proliferation and metabolism (e.g.: Myc, Max, Myb)74, effector function (e.g.: Fos, Rela, Stat1, Cebpb)75–77 as well as differentiation and epigenetic control (e.g.: Ets1, Yy1, Pou2f2)78 (Figure 6M).”
From Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy (2025) · cites this paper as [74]
Glutamine anaplerosis is critical for meeting the energetic requirements of proliferative cells, such as T cells during the transition from quiescent naïve T cells to effector cells, and in cancers, particularly with MYC elevation.
“Glutamine anaplerosis is critical for meeting the energetic requirements of proliferative cells, such as T cells during the transition from quiescent naïve T cells to effector cells, and in cancers, particularly with MYC elevation.32,36,37”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [36]
Catabolic pathways of ATP generation such as fatty acid β-oxidation are actively suppressed upon TCR activation.
“In addition, catabolic pathways of ATP generation such as fatty acid β-oxidation are actively suppressed (9).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [9]
OXPHOS is still engaged in effector T cells, but lactate production from aerobic glycolysis is the dominant pathway of glucose metabolism in effector T cells.
“It is important to note that OXPHOS is still engaged in TEFF cells (9); however, the production of lactate from pyruvate by aerobic glycolysis is the dominant pathway of glucose metabolism in TEFF cells.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [9]
TCR-mediated up-regulation of the transcription factors c-Myc and estrogen-related receptor α (ERRα) enhances the expression of genes involved in intermediary metabolism.
“TCR-mediated up-regulation of the transcription factors c-Myc (9) and estrogen-related receptor α (ERRα) (10) enhances the expression of genes involved in intermediary metabolism.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [9]
T cell activation promotes rapid increase in glucose flux through the oxidative pentose phosphate pathway.
“T cell activation promotes a rapid increase in glucose flux through the oxidative PPP (9).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [9]
Changes in expression of glutaminolysis genes correlate with enhanced glutaminolytic flux in lymphocytes.
“Glutamine transporters (SNAT1 and SNAT2) as well as key glutaminolysis enzymes (GLS, GPT, GOT, and GLUD) are up-regulated early after T cell activation similar to glycolysis genes (7, 9); several groups have correlated these changes in gene expression to enhanced glutaminolytic flux in lymphocytes (9, 53).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [9]
Glutamine transporters (SNAT1, SNAT2) and key glutaminolysis enzymes (GLS, GPT, GOT, GLUD) are up-regulated early after T cell activation similar to glycolysis genes.
“Glutamine transporters (SNAT1 and SNAT2) as well as key glutaminolysis enzymes (GLS, GPT, GOT, and GLUD) are up-regulated early after T cell activation similar to glycolysis genes (7, 9); several groups have correlated these changes in gene expression to enhanced glutaminolytic flux in lymphocytes (9, 53).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [9]
c-Myc is uniquely required for the initiation of aerobic glycolysis in activated T cells.
“Hif-1α is not required for the initiation of aerobic glycolysis in activated T cells; instead, c-Myc is uniquely required for this metabolic shift [111].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [111]
Hif-1α is not required for the initiation of aerobic glycolysis in activated T cells.
“Hif-1α is not required for the initiation of aerobic glycolysis in activated T cells; instead, c-Myc is uniquely required for this metabolic shift [111].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · cited 2× · see citing works
“The metabolic changes associated with T cell activation are reminiscent of the characteristic metabolic activities of tumor cells and may represent a general metabolic reprogramming during cell growth and proliferation (Kim and Dang, 2006; Vander Heiden et al., 2009; Warburg, 1956).”
BackgroundWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1× · see citing works
“The metabolic changes associated with T cell activation are reminiscent of the characteristic metabolic activities of tumor cells and may represent a general metabolic reprogramming during cell growth and proliferation (Kim and Dang, 2006; Vander Heiden et al., 2009; Warburg, 1956).”
BackgroundCluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 12,617 · cited 1× · see citing works
“The comparison of cytokine gene expression in resting and active T cells was visualized as heat maps with Cluster (Eisen and Brown, 1999) and TreeView (Eisen et al., 1998).”
MethodThe Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 2× · see citing works
“Whereas prokaryotes and unicellular eukaryotes rely primarily on homeostatic regulation of cell metabolism, metabolic programs in multicellular eukaryotes have evolved to be actively controlled by extracellular signals (Deberardinis et al., 2008).”
BackgroundArginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811 · see citing works
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622 · cited 1× · see citing works
“Metabolic flux analysis in a glioblastoma cell line further revealed that a major portion of glutamine-derived nitrogen and carbon are incorporated into amino acids and lactate, a fraction of which are secreted as metabolic by-products (DeBerardinis et al., 2007).”
BackgroundGao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · cited 3× · see citing works
“Recent studies in human cell lines have suggested that enforced expression of Myc regulates the rate-limiting glutaminolyic enzyme glutaminase 1 (Gls1) through both transcription and posttranscriptional mechanisms (Gao et al., 2009; Wise et al., 2008), and p53 regulates the transcription of glutaminase 2 (Gls2) (Hu et…”
BackgroundTumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051 · cited 2× · see citing works
“Animals Hif1a and p53-null mice on the C57BL/6 background were purchased from the Jackson Laboratory (Jacks et al., 1994; Ryan et al., 2000) and Hif1a mice were crossed with ROSA26CreERT2 (de Luca et al.”
MethodWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · cited 4× · see citing works
“Because a-KG is required to maintain cell viability and minimal cell proliferation in the absence of glutamine (Wise et al., 2008), addition of a-KG alone was sufficient to drive only one cell division in the absence of glutamine.”
BackgroundInfluentialShi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803 · cited 1× · see citing works
“To further test the dependency of T cell proliferation on glucose and glutamine catabolism in vivo, we applied 2DG and DON in an adoptive transfer model by using ovalbumin (OVA)specific, TCR-transgenic OT-II T cells (Figure 1G; Shi et al., 2011).”
MethodSelf-citationBidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798 · cited 4× · see citing works
“Because glutamine flux might regulate cell growth through the mTOR pathway (Nicklin et al., 2009), glutamine-dependent modulation of mTOR activation might partially account for the regulation of T cell growth by Myc.”
BackgroundInfluentialmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2× · see citing works
“, 2008), and the mammalian target of rapamycin (mTOR), an essential component of PI3K-Akt pathway, has recently been implicated in regulating fatty acid metabolism in memory T cells (Pearce et al., 2009; Araki et al., 2009).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 3× · see citing works
“, 2008), and the mammalian target of rapamycin (mTOR), an essential component of PI3K-Akt pathway, has recently been implicated in regulating fatty acid metabolism in memory T cells (Pearce et al., 2009; Araki et al., 2009).”
BackgroundThe CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475 · cited 5× · see citing works
“Signaling via ERK and AKT pathways has been implicated in the uptake of glutamine and glucose, respectively (Carr et al., 2010; Frauwirth et al., 2002; Wofford et al., 2008), and the mammalian target of rapamycin (mTOR), an essential component of PI3K-Akt pathway, has recently been implicated in regulating fatty acid…”
BackgroundResultInfluentialCancer's Molecular Sweet Tooth and the Warburg Effect
Kim, J., & Dang, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1501 · Cited by 1,217 · cited 1× · see citing works
“The metabolic changes associated with T cell activation are reminiscent of the characteristic metabolic activities of tumor cells and may represent a general metabolic reprogramming during cell growth and proliferation (Kim and Dang, 2006; Vander Heiden et al., 2009; Warburg, 1956).”
BackgroundDang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188 · cited 3× · see citing works
“Consistent with a direct role ofMyc in regulating cell proliferation (Dang et al., 2006; Eilers and Eisenman, 2008), addition of a-KG with HT and PAs failed to promote cell proliferation in Myc-deficient T cells (Figure S7C).”
BackgroundHnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179 · cited 1× · see citing works
“Notably, ectopic overexpression of Myc not only alters the transcription of several glycolytic genes but also preferentially switches the expression of PKM1 to PKM2 by modulating the alternative splicing of the PKM transcript (Dang and Semenza, 1999; David et al., 2010).”
BackgroundOncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106 · cited 7× · see citing works
“T cell activation-induced glycolysis and glutaminolysis is reminiscent of the metabolic changes in tumor cells, where both aerobic glycolysis (the Warburg effect) and glutaminoly- sis are driven by aberrant oncogenic signals (Dang and Semenza, 1999; Vander Heiden et al., 2009).”
BackgroundInfluential[12] DNA arrays for analysis of gene expression
Eisen, M. B., & Brown, P. O. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)03014-1 · Cited by 1,043 · cited 2× · see citing works
“The comparison of cytokine gene expression in resting and active T cells was visualized as heat maps with Cluster (Eisen and Brown, 1999) and TreeView (Eisen et al.”
MethodBrick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018 · cited 3× · see citing works
“Whereas prokaryotes and unicellular eukaryotes rely primarily on homeostatic regulation of cell metabolism, metabolic programs in multicellular eukaryotes have evolved to be actively controlled by extracellular signals (Deberardinis et al., 2008).”
BackgroundEilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927 · cited 3× · see citing works
“Consistent with a direct role ofMyc in regulating cell proliferation (Dang et al., 2006; Eilers and Eisenman, 2008), addition of a-KG with HT and PAs failed to promote cell proliferation in Myc-deficient T cells (Figure S7C).”
BackgroundSpandidos, A., Wang, X., Wang, H., & Seed, B. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1005 · Cited by 900 · cited 1× · see citing works
“Primer sequences were obtained from PrimerBank (Spandidos et al., 2010) except for Gls1 and Gls2, which were manually designed.”
MethodGlutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862 · cited 4× · see citing works
“Although recent studies indicate that the tumor suppressor p53 is required for the induction of GLS2 in a human tumor cell line (Hu et al., 2010; Suzuki et al., 2010),”
BackgroundInfluentialFuel feeds function: energy metabolism and the T-cell response
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · Nature reviews. Immunology · doi:10.1038/nri1710 · Cited by 841 · cited 1× · see citing works
“TCR- and costimulator-mediated signals drive T cell growth and clonal expansion, and coordinately reprogram metabolic cascades to fulfill the ensuing bioenergetic and biosynthetic demands (Fox et al., 2005; Krauss et al., 2001).”
BackgroundCarr, E. L., Kelman, A., Wu, G. S., Gopaul, R., Senkevitch, E., Aghvanyan, A., Turay, A. M., & Frauwirth, K. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903586 · Cited by 830 · cited 4× · see citing works
“Early studies have implicated the involvement of ERK-, AKT-, and mTOR-mediated signaling pathways in regulating T cell metabolism (Carr et al., 2010; Frauwirth et al., 2002; Pearce et al., 2009).”
BackgroundInfluentialModelling Myc inhibition as a cancer therapy
Soucek, L., Whitfield, J. R., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., & Evan, G. I. (2008) · Nature · doi:10.1038/nature07260 · Cited by 822 · cited 1× · see citing works
“We observed that acute depletion of Myc, in vivo, did not compromise the health of the animals over a period of 1 week, consistent with a recent report (Soucek et al., 2008).”
ResultHIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and Proliferation
Gordan, J. D., Thompson, C. B., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.006 · Cited by 806 · cited 4× · see citing works
“…and Myc were recently suggested to regulate 874 Immunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc. cell metabolism in transformed cells (Dang and Semenza, 1999; Gordan et al., 2007) and were highly induced at both the transcription and protein levels upon T cell activation (Figures 2D–2G).”
BackgroundInfluentialHypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000) · PubMed · Cited by 786 · see citing works
The ornithine decarboxylase gene is a transcriptional target of c-Myc.
Bello-Fernández, C., Packham, G., & Cleveland, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7804 · Cited by 783 · see citing works
Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002459107 · Cited by 705 · cited 4× · see citing works
“Although recent studies indicate that the tumor suppressor p53 is required for the induction of GLS2 in a human tumor cell line (Hu et al., 2010; Suzuki et al., 2010),”
BackgroundInfluentialEl Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., König, T., Schleicher, U., Koo, M.-S., et al. (2008) · Nature Immunology · doi:10.1038/ni.1671 · Cited by 646 · cited 1× · see citing works
“Arg1flox/flox; Tie2Cre mice that were backcrossed to the C57BL/6 background were obtained from P. Murray (SJCRH, Memphis) (El Kasmi et al., 2008).”
MethodHow Cells Coordinate Growth and Division
Jorgensen, P., & Tyers, M. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.027 · Cited by 559 · cited 1× · see citing works
“Consequently, one of the fundamental problems in animal cells is coordination of the metabolic program with cell growth- and proliferation-associated bioenergetic demand (Jorgensen and Tyers, 2004).”
BackgroundGLUTAMINE METABOLISM IN LYMPHOCYTES: ITS BIOCHEMICAL, PHYSIOLOGICAL AND CLINICAL IMPORTANCE
Newsholme, E. A., Crabtree, B., & Ardawi, M. S. M. (1985) · Quarterly Journal of Experimental Physiology · doi:10.1113/expphysiol.1985.sp002935 · Cited by 465 · cited 5× · see citing works
“Early studies showed that polyclonal mitogens such as concanavalin A and phytohaemagglutinin drive the upregulation of glycolysis and glutamine oxidation in thymocytes and mature lymphocytes (Brand et al., 1984; Newsholme et al., 1985b).”
BackgroundResultInfluentialc-Myc regulates mammalian body size by controlling cell number but not cell size
Trumpp, A., Refaeli, Y., Óskarsson, T., Gasser, S., Murphy, M., Martin, G. R., & Bishop, J. M. (2001) · Nature · doi:10.1038/414768a · Cited by 434 · cited 2× · see citing works
“Although Myc was suggested to be required for T cell proliferation and growth under most experimental conditions (Dose et al., 2006; Iritani et al., 2002), one study indicated that it is essential for cell proliferation but not cell growth (Trumpp et al., 2001).”
BackgroundWofford, J. A., Wieman, H. L., Jacobs, S. R., Zhao, Y., & Rathmell, J. C. (2007) · Blood · doi:10.1182/blood-2007-06-096297 · Cited by 424 · cited 2× · see citing works
“…via ERK and AKT pathways has been implicated in the uptake of glutamine and glucose, respectively (Carr et al., 2010; Frauwirth et al., 2002; Wofford et al., 2008), and the mammalian target of rapamycin (mTOR), an essential component of PI3K-Akt pathway, has recently been implicated in…”
BackgroundDynamic programming of CD8+ T lymphocyte responses
van Stipdonk, M. J. B., Hardenberg, G., Bijker, M. S., Lemmens, E. E., Droin, N. M., Green, D. R., & Schoenberger, S. P. (2003) · Nature Immunology · doi:10.1038/ni912 · Cited by 401 · cited 1× · see citing works
“During proliferation, T cells can undergo a cell division every 4–6 hr (van Stipdonk et al., 2003).”
BackgroundSelf-citationAnalysis of C-MYC Function in Normal Cells via Conditional Gene-Targeted Mutation
de Alborán, I. M., O’Hagan, R. C., Gärtner, F., Malynn, B. A., Davidson, L., Rickert, R. C., Rajewsky, K., DePinho, R. A., & Alt, F. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00088-7 · Cited by 398 · cited 2× · see citing works
“Mycflox/flox mice were obtained from F. Alt (Harvard) (de Alboran et al., 2001) and were backcrossed five generations onto the C56BL/6 background before breeding to ROSA26CreER(Tam) (Badea et al., 2003).”
Methodde Luca, C., Kowalski, T. J., Zhang, Y., Elmquist, J. K., Lee, C., Kilimann, M. W., Ludwig, T. E., Liu, S.-M., & Chua, S. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24059 · Cited by 383 · cited 2× · see citing works
“We generated a mouse model carrying a conditional HIF1a allele (Hif1aflox/flox) and a tamoxifen-inducible Cre recombinase (CreERT2) transgene (de Luca et al., 2005; Ryan et al., 2000) to delete HIF1a flox alleles in an acute manner.”
MethodMitochondrial metabolism of glutamine and glutamate and its physiological significance.
Kovacevic, Z., & McGivan, J. D. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.2.547 · Cited by 374 · cited 1× · see citing works
“Glutamine has long been known to be an indispensible nutrient for proliferating cells (Kovacevic and McGivan, 1983).”
BackgroundThe role of high rates of glycolysis and glutamine utilization in rapidly dividing cells
Newsholme, E. A., Crabtree, B., & Ardawi, M. S. (1985) · Bioscience Reports · doi:10.1007/bf01116556 · Cited by 364 · cited 5× · see citing works
“Early studies showed that polyclonal mitogens such as concanavalin A and phytohaemagglutinin drive the upregulation of glycolysis and glutamine oxidation in thymocytes and mature lymphocytes (Brand et al., 1984; Newsholme et al., 1985b).”
BackgroundResultInfluentialVella, A. T., Teague, T. K., Ihle, J. N., Kappler, J. W., & Marrack, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.325 · Cited by 289 · cited 1× · see citing works
“Freshly isolated murine primary T cells were either maintained in interleukin 7 (IL-7) (hereafter ‘‘resting T cells’’) (Vella et al., 1997) or were stimulated with anti-CD3 plus anti-CD28 (hereafter ‘‘active T cells’’).”
BackgroundBadea, T. C., Wang, Y., & Nathans, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02314.2003 · Cited by 256 · cited 4× · see citing works
“, 2001) and were backcrossed five generations onto the C56BL/6 background before breeding to ROSA26CreER(Tam) (Badea et al., 2003).”
BackgroundMethodInfluentialActivation changes the spectrum but not the diversity of genes expressed by T cells
Teague, T. K., Hildeman, D. A., Kedl, R. M., Mitchell, T., Rees, W. A., Schaefer, B. C., Bender, J., Kappler, J. W., & Marrack, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12691 · Cited by 223 · cited 2× · see citing works
“Antigen activation of T lymphocytes drives distinct transcriptional programs including upregulation of cell cycle and cytokine genes (Lu et al., 2004; Teague et al., 1999).”
BackgroundThe Metabolism of Proline as Microenvironmental Stress Substrate
Phang, J. M., Pandhare, J., & Liu, Y. (2008) · Journal of Nutrition · doi:10.1093/jn/138.10.2008s · Cited by 175 · cited 5× · see citing works
“Intriguingly, the metabolic enzymes Aldh18A1, Prodh, and OAT that link glutamine and proline to ornithine synthesis were induced in a Mycdependent manner upon T cell activation (Figures 7C and S5F), as were the metabolic enzymes, ODC, spermine synthase (SRM), and spermidine synthase (SMS), that convert ornithine to po…”
BackgroundInfluentialPASTAA: identifying transcription factors associated with sets of co-regulated genes
Roider, H. G., Manke, T., O'Keeffe, S., Vingron, M., & Haas, S. A. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btn627 · Cited by 154 · cited 3× · see citing works
“I Myc, but Not HIF1a, Is Required for Activation-Induced T Cell Metabolic Reprogramming With an in silico approach (Roider et al., 2009), transcription factors possibly involved in activation-induced T cell metabolic mmunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc. 873 (A andB) The…”
BackgroundMethodInfluentialSignaling Takes a Breath – New Quantitative Perspectives on Bioenergetics and Signal Transduction
Krauss, S., Brand, M. D., & Buttgereit, F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00205-9 · Cited by 147 · cited 1× · see citing works
“TCR- and costimulator-mediated signals drive T cell growth and clonal expansion, and coordinately reprogram metabolic cascades to fulfill the ensuing bioenergetic and biosynthetic demands (Fox et al., 2005; Krauss et al., 2001).”
Backgroundc-Myc mediates pre-TCR-induced proliferation but not developmental progression
Dose, M., Khan, I., Guo, Z., Kovalovsky, D., Krueger, A., von Boehmer, H., Khazaie, K., & Gounari, F. (2006) · Blood · doi:10.1182/blood-2006-02-005900 · Cited by 120 · cited 4× · see citing works
“…studies clearly demonstrate that Myc directly regulates T cell proliferation mainly through transcriptional control of cell cycle regulators (Dose et al., 2006; Iritani et al., 2002), our studies implicate Myc as an essential coordinator of T cell activation-induced cell growth,…”
BackgroundResultInfluentialWang, M., Windgassen, D., & Papoutsakis, E. T. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-225 · Cited by 117 · cited 1× · see citing works
“We compared our metabolic gene expression data of active mouse T lymphocytes with metabolic gene expression data from a recently published microarray study of active human T lymphocytes (Wang et al., 2008).”
ResultRecent advances in arginine metabolism
Morris, S. M. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200401000-00009 · Cited by 107 · see citing works
Iritani, B. M., Delrow, J. J., Grandori, C., Gomez, I. G., Klacking, M., Carlos, L. S., & Eisenman, R. N. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf492 · Cited by 97 · cited 4× · see citing works
“…demonstrate that Myc directly regulates T cell proliferation mainly through transcriptional control of cell cycle regulators (Dose et al., 2006; Iritani et al., 2002), our studies implicate Myc as an essential coordinator of T cell activation-induced cell growth, proliferation, and several…”
BackgroundResultInfluentialWidespread Expression of Arginase I in Mouse Tissues: Biochemical and Physiological Implications
Yu, H., Yoo, P. K., Aguirre, C., Tsoa, R. W., Kern, R. M., Grody, W. W., Cederbaum, S. D., & Iyer, R. K. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100905 · Cited by 83 · cited 2× · see citing works
“…action of arginase as part of the urea cycle (Morris, 2004), urea cycle enzymes including arginase were not induced upon activation (Figure S7D) nor were any defects in proliferation observed in T cells lacking arginase I (Figures 7A and 7B), the dominant isoform in the thymus (Yu et al., 2003).”
BackgroundGlucose and glutamine metabolism in rat thymocytes
Brand, K., Williams, J. F., & Weidemann, M. J. (1984) · Biochemical Journal · doi:10.1042/bj2210471 · Cited by 76 · cited 1× · see citing works
“Early studies showed that polyclonal mitogens such as concanavalin A and phytohaemagglutinin drive the upregulation of glycolysis and glutamine oxidation in thymocytes and mature lymphocytes (Brand et al., 1984; Newsholme et al., 1985b).”
BackgroundMapping the life histories of T cells
Schumacher, T., Gerlach, C., & van Heijst, J. V. (2010) · Nature reviews. Immunology · doi:10.1038/nri2822 · Cited by 63 · cited 1× · see citing works
“Coinciding with the clearance of antigen, effector T cells undergo an abrupt contraction phase in which the majority of T cells are eliminated by apoptosis (Green, 2003; Schumacher et al., 2010).”
BackgroundWu, G., Haynes, T. E., Li, H. Z., & Meininger, C. J. (2000) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(00)00196-3 · Cited by 61 · cited 1× · see citing works
“Previous studies in bovine endothelial and intestinal epithelial cells suggested the possible presence of a noncanonical metabolic pathway, which generates ornithine from glutamine (Wu et al., 2000; Wu and Morris, 1998).”
BackgroundLu, B., Zagouras, P., Fischer, J. E., Lu, J. F., Li, B., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307743100 · Cited by 54 · cited 2× · see citing works
“Antigen activation of T lymphocytes drives distinct transcriptional programs including upregulation of cell cycle and cytokine genes (Lu et al., 2004; Teague et al., 1999).”
BackgroundBowlin, T. L., McKown, B. J., Babcock, G. F., & Sunkara, P. S. (1987) · Cellular Immunology · doi:10.1016/0008-8749(87)90184-5 · Cited by 42 · cited 2× · see citing works
“Consistent with a previous study (Bowlin et al., 1987), difluoromethylornithine (DFMO), a potent inhibitor of ornithine decarboxylase (ODC) and polyamine biosynthesis, inhibited activation-induced T cell proliferation in vitro and in vivo (Figure 6F and 1H), and the addition of exogenous polyamines completely restored…”
ResultThe Role of Cyclin-Dependent Kinases in T-Cell Development, Proliferation, and Function
Rowell, E. A., & Wells, A. D. (2006) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v26.i3.10 · Cited by 33 · cited 2× · see citing works
“Consistent with previous work (Rowell and Wells, 2006), T cell activation was associated with downregulation of the cell cycle inhibitor p27, the upregulation of cyclins and cyclin-dependent kinases (CDKs), and the appearance of markers of S phase, such as the phosphorylation of RB and Cdc6 (Figure…”
BackgroundIntroduction: apoptosis in the development and function of the immune system
Green, D. R. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(03)00028-9 · Cited by 10 · cited 1× · see citing works
“Coinciding with the clearance of antigen, effector T cells undergo an abrupt contraction phase in which the majority of T cells are eliminated by apoptosis (Green, 2003; Schumacher et al., 2010).”
BackgroundSelf-citation
Flagged first, then by citations
1 of the 59 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · see citing works
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331 · see citing works
“We assessed the protein expression of glutamate dehydrogenase (Glud1), which catalyzes the oxidative deamination of glutamate to a-ketoglutarate, an important process for energy homeostasis in T cells (Wang et al., 2011).”
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390 · see citing works
“Loss of Myc was associated with profoundly diminished expression of genes involved in metabolism and the inability for normal primary T cells to grow and proliferate (Wang et al., 2011a).”
BackgroundA guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315 · see citing works
Top 10 Challenges in Cancer Immunotherapy
Hegde, P. S., & Chen, D. S. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.011 · Cited by 2,238 · see citing works
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204 · see citing works
“…of in-vitro-and in-vivoactivated T cells and found that both had high ECAR and OCR in comparison to naive cells (Figure 1A), indicating that activated T cells use both aerobic glycolysis and OXPHOS (Gatza et al., 2011; Michalek et al., 2011; van der Windt and Pearce, 2012; Wang et al., 2011).”
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119 · see citing works
“BPTES inhibition of hGA(124-551), a truncated form of human kidneytype glutaminase.”
BackgroundThe multifaceted contributions of mitochondria to cellular metabolism
Spinelli, J. B., & Haigis, M. C. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0124-1 · Cited by 1,935 · see citing works
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Geiger, R., Rieckmann, J. C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.031 · Cited by 1,775 · see citing works
Metabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692 · see citing works
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
Bock, K. D., Γεωργιάδου, Μ., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.037 · Cited by 1,559 · see citing works
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462 · see citing works
“Additionally, treating TH1 CD4+ T cells with PKM2activatorDASS,whichwill decrease intracellularPEP levels (data not shown) (Anastasiou et al., 2012), similarly suppressed the production of IFNg and CD40L (Figure S5C).”
BackgroundResultInfluentialStine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375 · see citing works
“Intriguingly, with nutrient starvation, diminished TOR activity attenuates cell growth through diminished expression of dMyc.”
BackgroundResultInfluentialFueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363 · see citing works
“It is important to note that OXPHOS is still engaged in TEFF cells (9); however, the production of lactate from pyruvate by aerobic glycolysis is the dominant pathway of glucosemetabolism in TEFF cells.”
BackgroundInfluentialSena, L. A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D. A., Wang, C.-R., Schumacker, P. T., Licht, J. D., Perlman, H., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.020 · Cited by 1,338 · see citing works
“The most dramatic change in T cell metabolism upon activation is a marked increase in glucose metabolism, which appears to be regulated by the PI3K and Akt pathway and the transcription factorsMyc and ERRa (Frauwirth et al., 2002;Michalek et al., 2011; Wang et al., 2011).”
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,304 · see citing works
“Activation of PI3K, Akt, and mTOR regulates the switch to anabolic metabolism and subsequent aerobic glycolysis via transcription factors including Myc and HIF-1 (MacIver et al., 2013; Wang et al., 2011).”
BackgroundThe tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
Ho, W. J., Jaffee, E. M., & Zheng, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0363-5 · Cited by 1,295 · see citing works
Metabolic Regulation of T Lymphocytes
MacIver, N. J., Michalek, R. D., & Rathmell, J. C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095956 · Cited by 1,244 · see citing works
“Recently, a role for c-Myc in T cell metabolism was found using an in silico approach to identify transcription factors whose gene targets correlated with changes in metabolic gene expression upon T cell stimulation (36).”
BackgroundMethodInfluentialFoxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil‐de‐Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,263 · see citing works
“Myc is a transcription factor that has important roles in upregulating glycolysis and glutaminolysis in activated T cells (Wang et al., 2011).”
BackgroundMetabolic Instruction of Immunity
Buck, M. D., Sowell, R., Kaech, S. M., & Pearce, E. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.004 · Cited by 1,232 · see citing works
“Increases in HIF-1α activity by culturing T cells in physiologic normoxia (~3–5% O2), genetic deletion of von Hippel-Lindau (VHL) factor, or inhibiting activity of the oxygen-sensing prolyl-hydroxylase (PHD) family of proteins, enhances CD8 T cell glycolysis and effector functions and promotes antitumor immunity (Clev…”
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195 · see citing works
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Leone, R. D., Zhao, L., Englert, J. M., Sun, I.-M., Oh, M.-H., Sun, I.-H., Arwood, M. L., Bettencourt, I. A., Patel, C. H., Wen, J., et al. (2019) · Science · doi:10.1126/science.aav2588 · Cited by 1,169 · see citing works
T cell metabolism drives immunity
Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151159 · Cited by 1,190 · see citing works
Metabolism of Inflammation Limited by AMPK and Pseudo-Starvation
O'Neill, L. A. J., & Hardie, D. G. (2013) · Nature · doi:10.1038/nature11862 · Cited by 1,133 · see citing works
Macintyre, A. N., Gerriets, V. A., Nichols, A., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.004 · Cited by 1,129 · see citing works
“In addition to the cMyc (Wang et al., 2011) and estrogenrelated receptor a (ERRa) (Michalek et al., 2011b) transcription factors that regulate T cell metabolism, mTOR and the PI3KAkt-mTORC1 signaling pathway can promote Glut1 cell-surface trafficking, glycolysis, and lipid synthesis (Düvel et al.,…”
Influentialc-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D. R., Tessarollo, L., Casellas, R. C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.033 · Cited by 1,075 · see citing works
“To confirm that Myc regulates total cellular RNA and mRNA levels, c-Myc null naive B cells were recovered from mice carrying a conditional Myc allele (Mycflox/flox) and a tamoxifen-inducible Cre recombinase CreERTam) (Wang et al., 2011) that were treated with tamoxifen for 3 days.”
Self-citationRegulation and function of mTOR signalling in T cell fate decisions
Chi, H. (2012) · Nature Reviews Immunology · doi:10.1038/nri3198 · Cited by 1,035 · see citing works
Self-citationSun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,060 · see citing works
Regulation of glycolysis by the hypoxia-inducible factor (HIF): Implications for cellular physiology
Kierans, S. J., & Taylor, C. T. (2021) · The Journal of Physiology · doi:10.1113/jp280572 · Cited by 1,015 · see citing works
“…including dendritic cells (Krawczyk et al. 2010), classically activated M1 macrophages (Michl et al. 1976), neutrophils (Sbarra & Karnovsky, 1959), lymphocytes (T cells (Frauwirth et al. 2002; Wang et al. 2011) and B cells (Doughty et al. 2006)) adopt a high-glycolytic phenotype once activated.”
BackgroundLinks between metabolism and cancerPreprint
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 991 · see citing works
“Quiescent primary human T cells and resting human B cells use FAO, but upon growth stimulation, these cells switch to glycolysis and glutaminolysis (Wang et al. 2011; Le et al. 2012).”
BackgroundMethodGlucose Metabolism Regulates T Cell Activation, Differentiation, and Functions
Palmer, C. S., Ostrowski, M., Balderson, B., Christian, N., & Crowe, S. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00001 · Cited by 992 · see citing works
“The immune quiescence of naïve T cells is accompanied by a catabolic metabolism, characterized by the breakdown of glucose, fatty acids, and amino acids to generate intermediate metabolites, which enter the mitochondrial TCA cycle (17).”
BackgroundImmunosenescence: molecular mechanisms and diseases
Liu, Z., Liang, Q., Ren, Y., Guo, C., Ge, X., Wang, L., Cheng, Q., Luo, P., Zhang, Y., & Han, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01451-2 · Cited by 1,023 · see citing works
“A fundamental change among T cells is enhanced aerobic glycolysis in response to increasing expression of glucose transporters (GLUTs) on the cell surface induced by the upregulation of glycolysis-related genes in a c-Myc-dependent manner.(124) Concomitant with increased glucose metabolism, multiple signaling pathways…”
BackgroundMitochondria in the Regulation of Innate and Adaptive Immunity
Weinberg, S. E., Sena, L. A., & Chandel, N. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.002 · Cited by 960 · see citing works
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J. G., Yu, Z., Roychoudhuri, R., Palmer, D. C., Muranski, P., Karoly, E. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69589 · Cited by 952 · see citing works
“Thus, we observed metabolic reprogramming from lipid oxidation to glycolysis to be one of the early metabolic switches during CD8 + T cell activation and differentiation, a finding consistent with recent observations in CD4 + T cells (17).”
Sinclair, L. V., Rolf, J., Emslie, E., Shi, Y.-B., Taylor, P. M., & Cantrell, D. A. (2013) · Nature Immunology · doi:10.1038/ni.2556 · Cited by 930 · see citing works
Metabolic regulation of immune responses
Ganeshan, K., & Chawla, A. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120236 · Cited by 926 · see citing works
“utilized a combination of mass-spectrum-based metabolomic and metabolic tracer studies to identify the transcriptional factor Myc as a critical regulator of glycolysis and glutaminolysis (97) (Table 1).”
BackgroundMethodDe novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C. N., Bähre, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3704 · Cited by 927 · see citing works
Glutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859 · see citing works
“F or p er so na l u se o nl y. lncRNA: long noncoding RNA PCGEM1: prostate cancer gene expression marker 1 RNF5: ubiquitin ligase ring finger protein ER: endoplasmic reticulum IL-4: interleukin-4 AMPK: AMP-activated protein kinase HIF1: hypoxia-inducible factor 1 OGDH: oxoglutarate dehydrogenase CPSI: carbamoyl phosph…”
BackgroundInfluentialKumagai, S., Koyama, S., Itahashi, K., Tanegashima, T., Lin, Y.-T., Togashi, Y., Kamada, T., Irie, T., Okumura, G., Kono, H., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.01.001 · Cited by 892 · see citing works
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877 · see citing works
Regulation and metabolic functions of mTORC1 and mTORC2.
Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 723 · see citing works
Unraveling the Complex Interplay Between T Cell Metabolism and Function
Geltink, R. I. K., Kyle, R. L., & Pearce, E. L. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053019 · Cited by 821 · see citing works
“In addition, TCR signals induce c-Myc, which enacts transcription of metabolic genes critical for T cell activation (16).”
BackgroundKeeping It All Going—Complement Meets Metabolism
Kolev, M. V., & Kemper, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00001 · Cited by 818 · see citing works
“Activation of T cells also enhances mitochondrial biogenesis, uptake of amino acids (AAs), and glutaminolysis (66, 67).”
BackgroundAerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
Peng, M., Yin, N., Chhangawala, S., Xu, K., Leslie, C. S., & Li, M. O. (2016) · Science · doi:10.1126/science.aaf6284 · Cited by 787 · see citing works
“S1B), likely due to hypoxia-inducible factor 1a (HIF-1a)– and c-Myc–induced transcription of Ldha (10, 11).”
BackgroundInfluentialDe Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation
Ghoneim, H. E., Fan, Y., Moustaki, A., Abdelsamed, H. A., Dash, P., Dogra, P., Carter, R., Awad, W., Neale, G. A. M., Thomas, P. G., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.007 · Cited by 792 · see citing works
“…with the cell’s proliferative potential. c-Myc has been shown to be essential for activationinduced metabolic reprogramming and antigen-driven proliferation of naive CD8 T cells (Wang et al., 2011), and our data revealed that the Myc locus acquires an exhaustion-associated de novo DMR (Figure 1I).”
Self-citationO’Sullivan, D., van der Windt, G. J. W., Huang, S. C.-C., Curtis, J. D., Chang, C.-H., Buck, M. D., Qiu, J., Smith, A. M., Lam, W. Y., DiPlato, L. M., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.005 · Cited by 790 · see citing works
“Importantly, although the data showing that memory T and Tn cells acquire more 2NBDG than Teff are surprising, they do not argue against a role for glucose and glycolysis in Teff cell proliferation or effector function (Chang et al., 2013; Fox et al., 2005; Jacobs et al., 2008; Wang et al., 2011).”
BackgroundInfluentialMetabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease
Smith, R. L., Soeters, M. R., Wüst, R. C. I., & Houtkooper, R. H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00211 · Cited by 787 · see citing works
Metabolic coordination of T cell quiescence and activation
Chapman, N. M., Boothby, M. R., & Chi, H. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0203-y · Cited by 749 · see citing works
Self-citationMitochondrial Metabolism as a Target for Cancer Therapy
Vasan, K., Werner, M., & Chandel, N. S. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.019 · Cited by 746 · see citing works
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
Gerriets, V. A., Kishton, R. J., Nichols, A., Macintyre, A. N., Inoue, M., Ilkayeva, O., Winter, P. S., Liu, X., Priyadharshini, B., Slawinska, M. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76012 · Cited by 729 · see citing works
Metabolic Reprogramming of Immune Cells in Cancer Progression
Biswas, S. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.001 · Cited by 713 · see citing works
“In activated T cells, c-Myc controlled metabolic reprogramming by regulating their metabolic transcriptome and thereby impacting glycolysis, glutaminolysis, and polyamine synthesis (Wang et al., 2011).”
BackgroundDistinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism
Johnson, M. O., Wolf, M. M., Madden, M. Z., Andrejeva, G., Sugiura, A., Contreras, D. C., Maseda, D., Liberti, M. V., Paz, K. G., Kishton, R. J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.001 · Cited by 702 · see citing works
“In addition to increased use of glucose in activated effector T cells, glutamine uptake andglutaminolysis are also upregulated (Carr et al., 2010; Wang et al., 2011).”
BackgroundDimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
Kornberg, M. D., Bhargava, P., Kim, P. M., Putluri, V., Snowman, A. M., Putluri, N., Calabresi, P. A., & Snyder, S. H. (2018) · Science · doi:10.1126/science.aan4665 · Cited by 687 · see citing works
The pentose phosphate pathway in health and disease
TeSlaa, T. A., Ralser, M., Fan, J., & Rabinowitz, J. D. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00863-2 · Cited by 690 · see citing works
The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo
Blagih, J., Coulombe, F., Vincent, E. E., Dupuy, F., Galicia-Vázquez, G., Yurchenko, E., Raissi, T. C., van der Windt, G. J. W., Viollet, B., Pearce, E. L., et al. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.030 · Cited by 659 · see citing works
“Transcription factors including Myc (Wang et al., 2011), estrogen-related receptor a (ERRa) (Michalek et al., 2011b), and the liver X receptors (LXRs) (Bensinger et al., 2008) facilitate T cell metabolic reprogramming by enhancing the expression of metabolic genes downstream of TCR signaling, which…”
BackgroundInfluentialMetabolites and the Tumour Microenvironment: From Cellular Mechanisms to Systemic Metabolism
Elia, I., & Haigis, M. C. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00317-z · Cited by 651 · see citing works
Metabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 661 · see citing works
Self-citationSerine is an essential metabolite for effector T cell expansion
Ma, E. H., Bantug, G., Griss, T., Condotta, S., Johnson, R. M., Samborska, B., Mainolfi, N., Suri, V., Guak, H., Balmer, M. L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.011 · Cited by 657 · see citing works
Amino Assets: How Amino Acids Support Immunity
Kelly, B. L., & Pearce, E. L. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.010 · Cited by 653 · see citing works
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 652 · see citing works
Glycolysis – a key player in the inflammatory response
Soto‐Heredero, G., Heras, M. M. G. D. L., Gabandé‐Rodríguez, E., Oller, J., & Mittelbrunn, M. (2020) · FEBS Journal · doi:10.1111/febs.15327 · Cited by 645 · see citing works
Fatty acid carbon is essential for dNTP synthesis in endothelial cells
Schoors, S., Bruning, U., Missiaen, R., Queiroz, K. C. S., Borgers, G., Elia, I., Zecchin, A., Cantelmo, A. R., Christen, S., Goveia, J., et al. (2015) · Nature · doi:10.1038/nature14362 · Cited by 646 · see citing works
CD8+ T cell metabolism in infection and cancer
Reina-Campos, M., Scharping, N. E., & Goldrath, A. W. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00537-8 · Cited by 574 · see citing works
Bharath, L. P., Agrawal, M., McCambridge, G., Nicholas, D. A., Hasturk, H., Liu, J., Jiang, K., Liu, R., Guo, Z., Deeney, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.015 · Cited by 614 · see citing works
“CD4+ T cells from O compared Y subjects produced less lactate 46 Cell Metabolism 32, 44–55, July 7, 2020 and had lower ECAR (Figures 2A–2D and S2A–S2D).”
InfluentialNormalization of CD4 + T cell metabolism reverses lupus
Yin, Y., Choi, S., Xu, Z., Perry, D. J., Seay, H. R., Croker, B. P., Sobel, E. S., Brusko, T. M., & Morel, L. M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0835 · Cited by 611 · see citing works
“The up-regulation of glycolysis results from a transcriptional reprogramming regulated by c-MYC, HIF1a (hypoxia-inducible factor 1a), and ERRa (estrogen-related receptor a) (12, 15, 16).”
BackgroundMetabolic barriers to cancer immunotherapy
DePeaux, K., & Delgoffe, G. M. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00541-y · Cited by 614 · see citing works
The regulation of immune tolerance by FOXP3
Lu, L., Barbi, J., & Pan, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.75 · Cited by 580 · see citing works
MYC, Metabolism, Cell Growth, and TumorigenesisPreprint
Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 600 · see citing works
“In certain cell models, resting cells use fatty acid oxidation as a means to generate ATP, maintain membrane potentials, and turn over organelles (Wang et al. 2011).”
BackgroundInfluentialFinlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112607 · Cited by 596 · see citing works
“In this respect, a previous study has implicated c-myc as a major regulator of glucose metabolism in T cells (Wang et al., 2011).”
BackgroundInfluentialRedox regulation of the immune response
Morris, G., Gevezova, M., Sarafian, V. S., & Maes, M. H. J. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00902-0 · Cited by 600 · see citing works
“It occurs in an environment of extreme inflammation and also plays a dominant role in neutrophil autophagy and survival via FAO (2011) [222].”
BackgroundInfluentialMolecular regulation of effector and memory T cell differentiation
Chang, J. T., Wherry, E. J., & Goldrath, A. W. (2014) · Nature Immunology · doi:10.1038/ni.3031 · Cited by 578 · see citing works
Regulatory circuits of T cell function in cancer
Speiser, D. E., Ho, P., & Verdeil, G. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.80 · Cited by 559 · see citing works
Metabolic switching and fuel choice during T‐cell differentiation and memory development
van der Windt, G. J. W., & Pearce, E. L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01150.x · Cited by 563 · see citing works
“Despite its quick induction, HIF-1a appeared dispensable for the initiation of metabolic changes and activation-associated proliferation in these T cells (21).”
BackgroundResultInfluentialThe emerging role and targetability of the TCA cycle in cancer metabolism
Anderson, N. M., Mucka, P., Kern, J. G., & Feng, H. (2017) · Protein & Cell · doi:10.1007/s13238-017-0451-1 · Cited by 558 · see citing works
“MYC-dependent cancer cells can utilize either GLUD or aminotransferases to convert glutamine to α-KG for the TCA cycle (Wise et al., 2008; Wang et al., 2011).”
BackgroundTargeting glutamine metabolism as a therapeutic strategy for cancer
Jin, J., Byun, J., Choi, Y., & Park, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00971-9 · Cited by 574 · see citing works
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Park, J. H., Pyun, W. Y., & Park, H. W. (2020) · Cells · doi:10.3390/cells9102308 · Cited by 558 · see citing works
“Myc upregulates the rate-limiting enzymes of the PPP, including G6PD and TKT [87].”
BackgroundKidani, Y., Elsaesser, H., Hock, M. B., Vergnes, L., Williams, K. J., Argus, J. P., Marbois, B. N., Komisopoulou, E., Wilson, E. B., Osborne, T. F., et al. (2013) · Nature Immunology · doi:10.1038/ni.2570 · Cited by 552 · see citing works
Caro‐Maldonado, A., Wang, R., Nichols, A., Kuraoka, M., Milasta, S., Sun, L., Gavin, A. L., Abel, E. D., Kelsoe, G. H., Green, D. R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302062 · Cited by 553 · see citing works
“Metabolic reprogramming in T cells is mediated through the induction of cMyc (5), a well-described regulator of glycolysis, glutaminolysis, and cell growth, together with the PI3K/Akt pathway (2).”
BackgroundMethodResultInfluentialSelf-citationMetabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Kishton, R. J., Sukumar, M., & Restifo, N. P. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.016 · Cited by 548 · see citing works
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Bunse, L., Pusch, S., Bunse, T., Sahm, F., Sanghvi, K., Friedrich, M., Alansary, D., Sonner, J. K., Green, E., Deumelandt, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0095-6 · Cited by 544 · see citing works
Patsoukis, N., Wang, Q., Strauss, L., & Boussiotis, V. A. (2020) · Science Advances · doi:10.1126/sciadv.abd2712 · Cited by 539 · see citing works
“Oxidative phosphorylation is the main source of energy for naive T cells, but upon activation, naïve T cells undergo metabolic reprogramming to aerobic glycolysis, also known as the Warburg effect, while simultaneously augmenting glutamine uptake and catabolism to maintain effector T cell fitness and drive differentia…”
BackgroundGlutathione primes t cell metabolism for inflammation
Mak, T. W., Grusdat, M., Duncan, G. S., Dostert, C., Nonnenmacher, Y., Cox, M., Binsfeld, C., Hao, Z., Brüstle, A., Itsumi, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.019 · Cited by 511 · see citing works
Analysis and Interpretation of Microplate-Based Oxygen Consumption and pH Data
Divakaruni, A. S., Paradyse, A. R., Ferrick, D. A., Murphy, A. N., & Jastroch, M. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801415-8.00016-3 · Cited by 525 · see citing works
MYC: Connecting selective transcriptional control to global RNA production
Kress, T. R., Sabò, A., & Amati, B. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3984 · Cited by 521 · see citing works
Klysz, D., Tai, X., Robert, P. A., Craveiro, M., Cretenet, G., Oburoglu, L., Mongellaz, C., Floess, S., Fritz, V., Matias, M. I., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aab2610 · Cited by 522 · see citing works
Changes in Nutritional Status Impact Immune Cell Metabolism and Function
Alwarawrah, Y., Kiernan, K., & MacIver, N. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01055 · Cited by 519 · see citing works
“For example, citrate is a TCA cycle intermediate that can be used as a precursor for lipid synthesis (95).”
BackgroundInfluentialRomero‐Garcia, S., Moreno‐Altamirano, M. M. B., Prado-Garcı́a, H., & Sánchez‐García, F. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00052 · Cited by 508 · see citing works
Saravia, J., Chapman, N. M., & Chi, H. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0220-6 · Cited by 489 · see citing works
Self-citationWei, J., Long, L., Yang, K., Guy, C., Shrestha, S., Chen, Z., Wu, C., Vogel, P., Neale, G., Green, D. R., et al. (2016) · Nature Immunology · doi:10.1038/ni.3365 · Cited by 470 · see citing works
Self-citationRedox regulation of immunometabolism
Muri, J., & Köpf, M. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00478-8 · Cited by 501 · see citing works
Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch
Gubser, P. M., Bantug, G. R., Razik, L., Fischer, M., Dimeloe, S., Höenger, G., Müller-Durovic, B., Jauch, A., & Hess, C. (2013) · Nature Immunology · doi:10.1038/ni.2687 · Cited by 487 · see citing works
Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis
Sabò, A., Kress, T. R., Pelizzola, M., de Pretis, S., Gorski, M. M., Tesi, A., Morelli, M. J., Bora, P., Doni, M., Verrecchia, A., et al. (2014) · Nature · doi:10.1038/nature13537 · Cited by 478 · see citing works
Transcriptional Control of Dendritic Cell Development
Murphy, T. L., Grajales‐Reyes, G. E., Wu, X., Tussiwand, R., Briseño, C. G., Iwata, A., Kretzer, N. M., Durai, V., & MURPHY, K. M. M. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120204 · Cited by 484 · see citing works
“c-Myc regulates proliferation and metabolism (173) and increases transcription by interactions with RNA polymerases (174–176).”
BackgroundPearce, E. J., & Everts, B. (2014) · Nature reviews. Immunology · doi:10.1038/nri3771 · Cited by 482 · see citing works
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Donnelly, R. P., Loftus, R. M., Keating, S. E., Liou, K. T., Biron, C. A., Gardiner, C. M., & Finlay, D. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401558 · Cited by 480 · see citing works
“Indeed, the metabolic changes described in this study to accompany NK cell activation are similar to those that occur in proinflammatory effector T cell subsets (2, 3, 26, 27).”
BackgroundLiu, W., Le, A., Hancock, C., Lane, A. N., Dang, C. V., Fan, T. W.-M., & Phang, J. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203244109 · Cited by 483 · see citing works
“The latter showed that MYC-driven glutamine catabolism couples with multiple biosynthetic pathways, especially ornithine and polyamine biosynthesis (28).”
BackgroundMetabolic pathways in T cell activation and lineage differentiation
Almeida, L., Lochner, M., Berod, L., & Sparwasser, T. D. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.10.009 · Cited by 475 · see citing works
“Additionally, the flux through glycolysis, PPP and the exosamine pathway also increases [15].”
BackgroundInfluentialPrograms for the persistence, vigilance and control of human CD8+ lung-resident memory T cells
Hombrink, P., Helbig, C., Backer, R. A., Piet, B., Oja, A. E., Stark, R., Brasser, G., Jongejan, A., Jonkers, R. E., Nota, B., et al. (2016) · Nature Immunology · doi:10.1038/ni.3589 · Cited by 455 · see citing works
Metabolic checkpoints in activated T cells
Wang, R., & Green, D. R. (2012) · Nature Immunology · doi:10.1038/ni.2386 · Cited by 457 · see citing works
Self-citationThe Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 473 · see citing works
- Authors
- Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., & Green, D. R.
- Affiliations
- St. Jude Children's Research Hospital (US)
- University of Rochester Medicine (US)
- Corresponding author
- Green, Douglas R.
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 35
- Issue
- 6
- Pages
- 871-882
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC3248798
- OpenAlex
- W2079999658
- Cited by
- 2,140
- References
- 59
- Citations by year
- 2026: 137 · 2025: 147 · 2024: 168 · 2023: 175 · 2022: 220 · 2021: 203 · 2020: 199 · 2019: 173 · 2018: 158 · 2017: 150 · 2016: 127 · 2015: 99 · 2014: 80 · 2013: 62 · 2012: 37
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service (S064599)
- National Institute of General Medical Sciences (R37GM052735, R01GM052735, GM-52735)
- National Institute of Allergy and Infectious Diseases (R01AI040646, R56AI081773, AI081773, R01AI081773, AI40646)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K01AR053573, AR053573)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- c-Myc, T cell activation, metabolic reprogramming, glycolysis, glutaminolysis, polyamine biosynthesis, HIF-1α, TCA cycle, pentose phosphate pathway, glutamine deprivation, nucleotides, T cell proliferation, transcription factors
- MeSH terms
- Animals, Gene Expression Regulation, Glucose, Glutamine, Lymphocyte Activation, Mice, Inbred C57BL, Ornithine, Polyamines, T-Lymphocytes, Proto-Oncogene Proteins c-myc, Mice, Knockout, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Metabolic Networks and Pathways, TOR Serine-Threonine Kinases, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review